References
- Cohuet G, Struijker-Boudier H. Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol Ther 2006;111:81-98. https://doi.org/10.1016/j.pharmthera.2005.09.002
- Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment? Circulation 2001;104:735-40. https://doi.org/10.1161/hc3101.091158
- Mourad JJ, Laville M. Is hypertension a tissue perfusion disorder? Implications for renal and myocardial perfusion. J Hypertens Suppl 2006;24:S10-6. https://doi.org/10.1097/01.hjh.0000240041.43214.8a
- Battegay EJ, de Miguel LS, Petrimpol M, Humar R. Effects of antihypertensive drugs on vessel rarefaction. Curr Opin Pharmacol 2007;7:151-7. https://doi.org/10.1016/j.coph.2006.09.007
- Redon J. Antihypertensive treatment: should it be titrated to blood pressure reduction or to target organ damage regression? Curr Opin Nephrol Hypertens 2005;14:448-52. https://doi.org/10.1097/01.mnh.0000168935.95527.0a
- Lee JS, Song SH, Kim JM, et al. Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor. Cardiovasc Res 2008;78:572-80. https://doi.org/10.1093/cvr/cvn048
- Olzinski AR, McCafferty TA, Zhao SQ, et al. Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection. Cardiovasc Res 2005;66:170-8. https://doi.org/10.1016/j.cardiores.2004.12.021
- Nakamura Y, Ono H, Zhou X, Frohlich ED. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats. Hypertension 2001;37:1262-7. https://doi.org/10.1161/01.HYP.37.5.1262
- Kubis N, Besnard S, Silvestre JS, et al. Decreased arteriolar density in endothelial nitric oxide synthase knockout mice is due to hypertension, not to the constitutive defect in endothelial nitric oxide synthase enzyme. J Hypertens 2002;20:273-80. https://doi.org/10.1097/00004872-200202000-00017
- Kubis N, Richer C, Domergue V, Giudicelli JF, Lévy BI. Role of microvascular rarefaction in the increased arterial pressure in mice lacking for the endothelial nitric oxide synthase gene (eNOS3pt-/- ). J Hypertens 2002;20:1581-7. https://doi.org/10.1097/00004872-200208000-00021
- Kim W, Moon SO, Lee SY, et al. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J Am Soc Nephrol 2006;17:2474-83. https://doi.org/10.1681/ASN.2006020109
- Cho CH, Kammerer RA, Lee HJ, et al. Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc Natl Acad Sci U S A 2004;101:5553-8. https://doi.org/10.1073/pnas.0307575101
- Cho CH, Sung HK, Kim KT, et al. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc Natl Acad Sci U S A 2006;103:4946-51. https://doi.org/10.1073/pnas.0506352103
- Kobori H, Ozawa Y, Suzaki YY, Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 2005;16:2073-80. https://doi.org/10.1681/ASN.2004080676
- Du WM, Miao CY, Liu JG, Shen FM, Yang XQ, Su DF. Effects of long-term treatment with ketanserin on blood pressure variability and end-organ damage in spontaneously hypertensive rats. J Cardiovasc Pharmacol 2003;41:233-9. https://doi.org/10.1097/00005344-200302000-00012
- Noon JP, Walker BR, Webb DJ, et al. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997;99:1873-9. https://doi.org/10.1172/JCI119354
- Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 1999;34: 655-8. https://doi.org/10.1161/01.HYP.34.4.655
- Antonios TF, Rattray FM, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart 2003;89:175-8. https://doi.org/10.1136/heart.89.2.175
- Jung AD, Kim W, Park SH, et al. The effect of telmisartan on endothelial function and arterial stiffness in patients with essential hypertension. Korean Circ J 2009;39:180-4. https://doi.org/10.4070/kcj.2009.39.5.180
Cited by
- Clinical significance of Angiopoietin-1 in Behcet’s disease patients with vascular involvement vol.31, pp.6, 2011, https://doi.org/10.1007/s00380-015-0686-9